Skip to main content

RAPT Therapeutics, Inc.

RAPTDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001673772

RAPT Therapeutics, Inc. was delisted in 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by RAPT Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for RAPT Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for RAPT Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Gray Mary AnnDirector0Mar 5, 20262
Dombkowski Ashley L.Director0Mar 5, 20262
Young Rodney KBCHIEF FINANCIAL OFFICER0Mar 5, 20261
Brockstedt Dirk G.CHIEF SCIENTIFIC OFFICER0Mar 5, 20261
Braunstein ScottDirector0Mar 5, 20262
Wong Brian RussellPRESIDENT AND CEO0Mar 5, 20261
Lyons-Williams LoriDirector0Mar 5, 20262
Giordano Michael FDirector0Mar 5, 20262
Kozick LindaDirector0Mar 5, 20262
Ho WilliamCHIEF MEDICAL OFFICER15,020Jun 24, 20250
Robbins WendyeDirector6,500IndirectApr 2, 20250
Column Group II, LPOther: Former 10% Owner0IndirectDec 23, 20240
Column Group IV-A, LP10% Owner0IndirectDec 23, 20240
Column Group IV, LP10% Owner0IndirectDec 23, 20240
Column Group IV GP, LP10% Owner0IndirectDec 23, 20240
TCG IV GP, LLC10% Owner0IndirectDec 23, 20240
Goeddel David V10% Owner0IndirectDec 23, 20240
Svennilson Peter10% Owner0IndirectDec 23, 20240
Kutzkey Tim10% Owner0IndirectDec 23, 20240
Column Group II GP, LP10% Owner0IndirectDec 23, 20240
Ponoi Capital, LP10% Owner0IndirectDec 23, 20240
Ponoi Management, LLC10% Owner0IndirectDec 23, 20240
Ponoi Capital II, LP10% Owner0IndirectDec 23, 20240
Ponoi II Management, LLC10% Owner0IndirectDec 23, 20240
Column Group LLC10% Owner0IndirectDec 23, 20240
Rieflin William JLDirector–May 23, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 8, 2024 (view filing)Jan 53 daysBrockstedt Dirk G.CHIEF SCIENTIFIC OFFICERSSale−898$22.78−$20.5K−3.1%27.8K after
Dec 22, 2023 (view filing)Dec 211 dayHo WilliamChief Medical OfficerSSale−2.50K$21.68−$54.2K−14.3%15.0K after
Nov 29, 2023 (view filing)Nov 281 dayHo WilliamChief Medical OfficerSSale−1.50K$13.72−$20.6K−7.9%17.5K after
Oct 4, 2023 (view filing)Oct 31 dayHo WilliamChief Medical OfficerSSale−2.50K$15.77−$39.4K−11.7%18.8K after
Aug 22, 2023 (view filing)Aug 184 daysHo WilliamChief Medical OfficerSSale−2.50K$18.92−$47.3K−10.5%21.3K after
Apr 20, 2023 (view filing)Apr 191 dayHo WilliamChief Medical OfficerSSale−5.00K$18.88−$94.4K−19.2%21.0K after
Mar 15, 2023 (view filing)Mar 141 dayRobbins WendyeDirectorPPurchase+2.50K$18.99+$47.5K+20.2%14.9K after3 lots
Mar 15, 2023 (view filing)Mar 141 dayRobbins WendyeDirectorPPurchase+2.50K$20.05+$50.1K+62.5%6.50K after
Mar 13, 2023 (view filing)Mar 76 daysLateHo WilliamChief Medical OfficerSSale−5.00K$29.62−$148.1K−16.4%25.5K after
Jan 26, 2023 (view filing)Jan 242 daysHo WilliamChief Medical OfficerSSale−5.00K$30.00−$150.0K−14.3%30.1K after
Jan 20, 2023 (view filing)Jan 191 dayHo WilliamChief Medical OfficerSSale−5.00K$25.56−$127.8K−12.5%35.1K after
Jan 9, 2023 (view filing)Jan 54 daysBrockstedt Dirk G.Chief Scientific OfficerSSale−742$21.97−$16.3K−3.7%19.1K after
Dec 30, 2022 (view filing)Dec 291 dayHo WilliamChief Medical OfficerSSale−5.00K$18.03−$90.2K−11.7%37.6K after
Nov 29, 2022 (view filing)Nov 281 dayHo WilliamChief Medical OfficerSSale−5.00K$17.87−$89.3K−10.5%42.6K after
Nov 3, 2022 (view filing)Nov 21 dayHo WilliamChief Medical OfficerSSale−5.00K$22.32−$111.6K−9.5%47.6K after
Oct 14, 2022 (view filing)Oct 131 dayHo WilliamChief Medical OfficerSSale−2.00K$21.52−$43.0K−3.7%52.6K after
Aug 31, 2022 (view filing)Aug 301 dayHo WilliamChief Medical OfficerSSale−2.50K$28.13−$70.3K−4.5%53.0K after
Jul 13, 2022 (view filing)Jul 112 daysHo WilliamChief Medical OfficerSSale−2.00K$19.95−$39.9K−3.7%52.3K after
May 27, 2022 (view filing)4:29 PM ETMay 252 daysColumn Group II, LP and 4 others10% OwnerPPurchase+1.90K$12.45+$23.7K+4.7%42.2K after2 lotsDuplicate filing
May 27, 2022 (view filing)4:24 PM ETMay 252 daysGoeddel David V and 9 others10% OwnerPPurchase+1.90K$12.45+$23.7K+4.7%42.2K after2 lots
May 25, 2022 (view filing)4:20 PM ETMay 23-242 daysColumn Group II, LP and 4 others10% OwnerPPurchase+26.6K$12.19+$323.7K+170.5%42.1K after4 lotsDuplicate filing
May 25, 2022 (view filing)4:19 PM ETMay 23-242 daysGoeddel David V and 9 others10% OwnerPPurchase+26.6K$12.19+$323.7K+170.5%42.1K after4 lots
May 12, 2022 (view filing)5:29 PM ETMay 102 daysColumn Group II, LP and 4 others10% OwnerPPurchase+1.25M$10.67+$13.3MNew position41.3K after2 lotsDuplicate filing
May 12, 2022 (view filing)5:28 PM ETMay 102 daysGoeddel David V and 9 others10% OwnerPPurchase+1.25M$10.67+$13.3MNew position41.3K after2 lots
May 12, 2022 (view filing)May 102 daysYoung Rodney KBChief Financial OfficerPPurchase+5.00K$10.53+$52.6K+98.3%10.1K after
May 12, 2022 (view filing)May 102 daysRobbins WendyeDirectorPPurchase+4.50K$11.24+$50.6K+48.4%13.8K after2 lots
May 12, 2022 (view filing)May 102 daysRobbins WendyeDirectorPPurchase+2.50K$10.68+$26.7K+166.7%4.00K after4 lots
May 5, 2022 (view filing)May 41 dayBrockstedt Dirk G.Chief Scientific OfficerSSale−720$15.05−$10.8K−3.5%19.8K after
Apr 12, 2022 (view filing)Apr 111 dayBrockstedt Dirk G.Chief Scientific OfficerSSale−2.65K$23.05−$61.0K−11.8%19.8K after
Apr 7, 2022 (view filing)Apr 61 dayHo WilliamChief Medical OfficerSSale−3.00K$22.96−$68.9K−5.3%53.4K after
Mar 14, 2022 (view filing)Mar 113 daysBrockstedt Dirk G.Chief Scientific OfficerSSale−2.65K$23.91−$63.3K−11.8%19.8K after
Feb 28, 2022 (view filing)Feb 28Same dayHo WilliamChief Medical OfficerSSale−3.00K$18.79−$56.4K−5.1%55.7K after
Feb 14, 2022 (view filing)Feb 113 daysBrockstedt Dirk G.Chief Scientific OfficerSSale−2.65K$22.47−$59.5K−11.8%19.8K after
Jan 14, 2022 (view filing)Jan 131 dayHo WilliamChief Medical OfficerSSale−3.00K$30.67−$92.0K−4.9%57.9K after
Jan 13, 2022 (view filing)Jan 112 daysBrockstedt Dirk G.Chief Scientific OfficerSSale−2.65K$32.16−$85.2K−11.8%19.8K after
Jan 6, 2022 (view filing)Jan 51 dayHo WilliamChief Medical OfficerSSale−2.00K$40.00−$80.0K−3.2%60.9K after
Dec 13, 2021 (view filing)Dec 103 daysBrockstedt Dirk G.Chief Scientific OfficerSSale−2.65K$30.88−$81.7K−11.8%19.8K after
Dec 10, 2021 (view filing)Nov 1129 daysLateBrockstedt Dirk G.Chief Scientific OfficerSSale−2.65K$35.69−$94.5K−11.8%19.8K after
Dec 6, 2021 (view filing)Dec 33 daysHo WilliamChief Medical OfficerSSale−3.00K$32.26−$96.8K−5.0%57.1K after
Oct 19, 2021 (view filing)Oct 181 dayRobbins WendyeDirectorPPurchase+500$30.70+$15.3K+5.7%9.30K after
Oct 15, 2021 (view filing)Oct 132 daysRobbins WendyeDirectorPPurchase+400$29.69+$11.9K+4.8%8.80K after
Oct 14, 2021 (view filing)Oct 131 dayHo WilliamChief Medical OfficerSSale−3.00K$29.69−$89.1K−4.8%60.1K after
Oct 12, 2021 (view filing)Oct 111 dayBrockstedt Dirk G.Chief Scientific OfficerSSale−2.65K$30.78−$81.5K−11.8%19.8K after
Sep 29, 2021 (view filing)4:58 PM ETSep 272 daysGoeddel David V and 9 others10% OwnerSSale−9.24K$34.57−$319.4K−100.0%0 after3 lots
Sep 22, 2021 (view filing)Sep 202 daysHo WilliamChief Medical OfficerSSale−2.00K$40.00−$80.0K−3.1%63.1K after
Sep 20, 2021 (view filing)Sep 173 daysHo WilliamChief Medical OfficerSSale−2.00K$38.97−$77.9K−3.1%63.1K after5 lots
Sep 16, 2021 (view filing)5:16 PM ETSep 14-152 daysGoeddel David V and 9 others10% OwnerSSale−181.2K$37.01−$6.71M−100.0%0 after13 lots
Sep 14, 2021 (view filing)5:31 PM ETSep 10-134 daysGoeddel David V and 9 others10% OwnerSSale−36.1K$35.22−$1.27M−49.6%36.6K after6 lots
Sep 13, 2021 (view filing)Sep 103 daysBrockstedt Dirk G.Chief Scientific OfficerSSale−2.65K$35.78−$94.7K−11.8%19.8K after
Sep 9, 2021 (view filing)Sep 81 dayHo WilliamChief Medical OfficerSSale−3.00K$36.04−$108.1K−4.4%65.1K after